LB Pharmaceuticals Inc (LBRX)
NASDAQ: LBRX · Real-Time Price · USD
30.90
-0.51 (-1.62%)
Jul 20, 2026, 4:00 PM EDT - Market closed
LB Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst BMO Capital No rating | BMO Capital | Buy Initiates $46 | Buy | Initiates | $46 | +48.87% | Jul 20, 2026 |
| Wolfe Research | Wolfe Research | Buy Initiates $45 | Buy | Initiates | $45 | +45.63% | Jul 7, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $45 | Buy | Reiterates | $45 | +45.63% | Jun 25, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Reiterates $36 | Buy | Reiterates | $36 | +16.50% | Jun 11, 2026 |
| Clear Street | Clear Street | Buy Initiates $45 | Buy | Initiates | $45 | +45.63% | May 26, 2026 |
| Roth MKM | Roth MKM | Buy Reiterates $30 → $37 | Buy | Reiterates | $30 → $37 | +19.74% | May 17, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $78 | Buy | Maintains | $78 | +152.43% | May 13, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates $35 → $40 | Buy | Reiterates | $35 → $40 | +29.45% | Mar 27, 2026 |